Eight Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Psygenpsygen.cain𝕏Mar 2021
Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use.
BiotechDeep TechHealthtechMedical DevicesMental Health
Danny Motyka(Co-Founder & CEO)inPeter van der Heyden(Co-Founder & Director)in
Co-investorsIter InvestmentsNoetic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.